AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.8 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Intelligent Ophthalmology | Open Access

Research on classification method of high myopic maculopathy based on retinal fundus images and optimized ALFA-Mix active learning algorithm

Shao-Jun Zhu1,2Hao-Dong Zhan1,2Mao-Nian Wu1,2Bo Zheng1,2Bang-Quan Liu3Shao-Chong Zhang4( )Wei-Hua Yang4( )
Huzhou University, School of Information Engineering, Huzhou 313000, Zhejiang Province, China
Zhejiang Province Key Laboratory of Smart Management & Application of Modern Agricultural Resources, Huzhou University, Huzhou 313000, Zhejiang Province, China
College of Digital Technology and Engineering, Ningbo University of Finance & Economics, Ningbo 315175, Zhejiang Province, China
Shenzhen Eye Institute, Shenzhen Eye Hospital, Jinan University, Shenzhen 518048, Guangdong Province, China
Show Author Information

Abstract

AIM

To conduct a classification study of high myopic maculopathy (HMM) using limited datasets, including tessellated fundus, diffuse chorioretinal atrophy, patchy chorioretinal atrophy, and macular atrophy, and minimize annotation costs, and to optimize the ALFA-Mix active learning algorithm and apply it to HMM classification.

METHODS

The optimized ALFA-Mix algorithm (ALFA-Mix+) was compared with five algorithms, including ALFA-Mix. Four models, including ResNet18, were established. Each algorithm was combined with four models for experiments on the HMM dataset. Each experiment consisted of 20 active learning rounds, with 100 images selected per round. The algorithm was evaluated by comparing the number of rounds in which ALFA-Mix+ outperformed other algorithms. Finally, this study employed six models, including EfficientFormer, to classify HMM. The best-performing model among these models was selected as the baseline model and combined with the ALFA-Mix+ algorithm to achieve satisfactory classification results with a small dataset.

RESULTS

ALFA-Mix+ outperforms other algorithms with an average superiority of 16.6, 14.75, 16.8, and 16.7 rounds in terms of accuracy, sensitivity, specificity, and Kappa value, respectively. This study conducted experiments on classifying HMM using several advanced deep learning models with a complete training set of 4252 images. The EfficientFormer achieved the best results with an accuracy, sensitivity, specificity, and Kappa value of 0.8821, 0.8334, 0.9693, and 0.8339, respectively. Therefore, by combining ALFA-Mix+ with EfficientFormer, this study achieved results with an accuracy, sensitivity, specificity, and Kappa value of 0.8964, 0.8643, 0.9721, and 0.8537, respectively.

CONCLUSION

The ALFA-Mix+ algorithm reduces the required samples without compromising accuracy. Compared to other algorithms, ALFA-Mix+ outperforms in more rounds of experiments. It effectively selects valuable samples compared to other algorithms. In HMM classification, combining ALFA-Mix+ with EfficientFormer enhances model performance, further demonstrating the effectiveness of ALFA-Mix+.

References

【1】
【1】
 
 
International Journal of Ophthalmology
Pages 995-1004

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Zhu S-J, Zhan H-D, Wu M-N, et al. Research on classification method of high myopic maculopathy based on retinal fundus images and optimized ALFA-Mix active learning algorithm. International Journal of Ophthalmology, 2023, 16(7): 995-1004. https://doi.org/10.18240/ijo.2023.07.01

466

Views

32

Downloads

10

Crossref

9

Web of Science

15

Scopus

0

CSCD

Received: 17 April 2023
Accepted: 16 May 2023
Published: 18 July 2023
© 2023 International Journal of Ophthalmology Press

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).